Prelude Therapeutics Incorporated
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Prelude Therapeutics Incorporated's balance sheet done over the years? Its assets were worth $277,665,000 last year, which is more than in the previous period. 15% of Prelude Therapeutics Incorporated’s total assets is currently financed by debt. Its liabilities reached the amount of $40,575,000, which means an increase by 62% compared compared to last year.

Debt to Assets

Prelude Therapeutics Incorporated (NASDAQ:PRLD): Debt to assets
2018 16406000 39.09M 238.32%
2019 21871000 71.28M 325.92%
2020 223590000 11.40M 5.1%
2021 305098000 19.20M 6.29%
2022 220500000 25.06M 11.37%
2023 277665000 40.57M 14.61%

PRLD Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
25.29M30.60M31.82M218.30M18.87M15.59M
Short term investments
207.64M171.12M259.40M000
Net receivables
000000
Inventory
000000
Other current assets
2.65M2.65M3.88M2.5M1.34M0
Total current assets
235.58M204.38M295.11M220.80M20.22M15.59M
Non-current assets:
Property, Plant and Equipment
37.73M6.7M5.63M2.48M1.64M811K
Goodwill
000000
Intangible assets
000000
Long term investments
04.04M4.04M000
Other non-current assets
4.33M5.37M303.00K301K00
Total non-current assets
42.07M16.12M9.98M2.78M1.64M811K
Total assets
277.66M220.5M305.09M223.59M21.87M16.40M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000000
Short term debt
2.96M1.83M1.74M0258K0
Total current liabilities
21.82M21.70M19.20M11.37M4.83M2.44M
Non-current liabilities:
Long term debt
15.40M00000
Deferred tax
000000
Other non-current liabilities
3.33M3.36M032K66.44M36.65M
Total non-current liabilities
18.74M3.36M032K66.44M36.65M
Total liabilities
40.57M25.06M19.20M11.40M71.28M39.09M
Data sourceData sourceData sourceData source